Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways

  • Kengo Shimazu1, 2, 3,
  • Yuji Tada1,
  • Takao Morinaga2,
  • Masato Shingyoji4,
  • Ikuo Sekine5,
  • Hideaki Shimada6,
  • Kenzo Hiroshima7,
  • Takao Namiki3,
  • Koichiro Tatsumi1 and
  • Masatoshi Tagawa2, 8Email author
Contributed equally
BMC Cancer201717:309

https://doi.org/10.1186/s12885-017-3300-y

Received: 20 August 2016

Accepted: 25 April 2017

Published: 2 May 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
20 Aug 2016 Submitted Original manuscript
1 Sep 2016 Author responded Author comments - Masatoshi Tagawa
Resubmission - Version 2
1 Sep 2016 Submitted Manuscript version 2
21 Nov 2016 Reviewed Reviewer Report - Carlos J. Ciudad
9 Feb 2017 Reviewed Reviewer Report - Frances Lennon
11 Mar 2017 Author responded Author comments - Masatoshi Tagawa
Resubmission - Version 3
11 Mar 2017 Submitted Manuscript version 3
12 Apr 2017 Author responded Author comments - Kengo Shimazu
Resubmission - Version 4
12 Apr 2017 Submitted Manuscript version 4
18 Apr 2017 Author responded Author comments - Kengo Shimazu
Resubmission - Version 5
18 Apr 2017 Submitted Manuscript version 5
Publishing
25 Apr 2017 Editorially accepted
2 May 2017 Article published 10.1186/s12885-017-3300-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Respirology, Graduate School of Medicine, Chiba University
(2)
Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute
(3)
Department of Japanese-Oriental Medicine, Graduate School of Medicine, Chiba University
(4)
Division of Respirology
(5)
Department of Medical Oncology, Faculty of Medicine, University of Tsukuba
(6)
Department of Surgery, School of Medicine, Toho University
(7)
Department of Pathology, Tokyo Women’s Medical University Yachiyo Medical Center
(8)
Department of Molecular Biology and Oncology, Graduate School of Medicine, Chiba University

Advertisement